SecBot SecBot
8-K ·Filed May 4, 2026

ADUS

Addus HomeCare Corp
NEUTRAL
Impact 4/10
Horizondays Processed6mo ago SEC0001437749-26-014653
8-K Item 2.02: Earnings release
Actionable Insight • Neutral

The earnings beat was modest and no formal guidance was provided. Watch for management's tone on the conference call regarding organic growth sustainability and acquisition pipeline. The home health segment's continued decline is a risk to monitor.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$98.44
T+0 close · May 4, 2026 · via day close
Latest settled
+18.53%
T+60 · $116.68
Vs SPY
+15.79%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 5 $98.44entry
  2. T+1 · 7mo ago −1.83%α −3.21% · $96.64
  3. T+5 · 6mo ago +0.05%α −1.93% · $98.49
  4. T+20 · 6mo ago −8.12%α −13.07% · $90.45
  5. T+60 · 4mo ago +18.53%α +15.79% · $116.68

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Addus HomeCare reported Q1 2026 revenue of $363.6M (+7.7% YoY) and GAAP EPS of $1.36 (+17.2% YoY), modestly beating consensus. The company also announced a small Indiana acquisition (HomeCourt Home Care, ~$9.7M annualized revenue). The results were solid but lacked explicit forward guidance, so the stock may trade flat to slightly positive.

Key Financial Metrics

EPS
$1.36
est $1.33 · +2.3%
Rating
beat
Gross Margin
31.9%

Key Facts

  • Q1 2026 net service revenue $363.6M, up 7.7% YoY from $337.7M
  • GAAP net income $25.1M ($1.36 per diluted share) vs $21.2M ($1.16) YoY
  • Adjusted net income per diluted share $1.62, up 14.1% YoY from $1.42
  • Adjusted EBITDA $44.5M, up 9.7% YoY from $40.6M
  • Operating cash flow $52.4M vs $18.9M in Q1 2025
  • Personal care organic revenue growth 6.5%; hospice organic growth 7.7%; home health revenue declined 6.6%
  • Acquired HomeCourt Home Care (Indiana) on May 1, 2026, with ~$9.7M annualized revenues
  • Entered definitive agreement for another Indiana acquisition of similar size

Financial Impact

Revenue grew $25.9M YoY; EPS beat consensus by $0.03 (2.3%); adjusted EPS grew $0.20 YoY

revenueepsebitdacash flow

Risk Factors

  • Home health segment revenue declined 6.6% YoY, continuing a multi-quarter trend
  • No explicit forward guidance provided; reliance on qualitative commentary
  • Integration of small acquisitions may not materially move the needle

Market Snapshot

Exchange
Nasdaq
Sector
Services-Home Health Care Services
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-014653
Document: adus20260504_8k.htm0001437749-26-014653
Document: 0001437749-26-014653-index-headers.html0001437749-26-014653
Document: 0001437749-26-014653-index.html0001437749-26-014653
Document: 0001437749-26-014653.txt0001437749-26-014653
8-K Data (Synthetic)0001437749-26-014653

US Market Status

Market Closed · Opens in 8h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026